Development of small-molecule probes that selectively kill cells induced to express mutant RAS.
Synthetic lethal screening is a chemical biology approach to identify small molecules that selectively kill oncogene-expressing cell lines with the goal of identifying pathways that provide specific targets against cancer cells. We performed a high-throughput screen of 303,282 compounds from the National Institutes of Health-Molecular Libraries Small Molecule Repository (NIH-MLSMR) against immortalized BJ fibroblasts expressing HRAS(G12V) followed by a counterscreen of lethal compounds in a series of isogenic cells lacking the HRAS(G12V) oncogene. This effort led to the identification of two novel molecular probes (PubChem CID 3689413, ML162 and CID 49766530, ML210) with nanomolar potencies and 4-23-fold selectivities, which can potentially be used for identifying oncogene-specific pathways and targets in cancer cells.
|Year of Publication||
Bioorg Med Chem Lett
2012 Feb 15
|PubMed Central ID||
R03MH084117 / MH / NIMH NIH HHS / United States
R03 MH084117 / MH / NIMH NIH HHS / United States
U54 HG005032 / HG / NHGRI NIH HHS / United States
R01CA097061 / CA / NCI NIH HHS / United States
R01 CA161061 / CA / NCI NIH HHS / United States
R01 GM085081 / GM / NIGMS NIH HHS / United States
1 U54 HG005032-1 / HG / NHGRI NIH HHS / United States
R01 CA097061 / CA / NCI NIH HHS / United States
Howard Hughes Medical Institute / United States